French health reform bill to address drug shortages, clinical trials
This article was originally published in SRA
Executive Summary
The French parliament is preparing to examine a bill reforming the healthcare system as part of the national health strategy launched by the government in 20131. While the main thrust of the draft "Health Law" is to iron out inequalities and inefficiencies in the healthcare system, it includes proposals to avoid shortages of high therapeutic value medicines and to bring French legislation into line with the new EU Clinical Trials Regulation.